Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of the BMPR2-Activin Signaling Pathway as a Key Mediator in Group II Pulmonary Hypertension. BREATHE-PH Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07537517
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:08.166803+00:00
Published At
2026-04-17T00:00:00+00:00
Record Updated At
2026-04-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pulmonary Hypertension Due to Left Heart Disease", "Pulmonary Hypertension (PH)", "Heart Failure"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-17"
protocolSection.identificationModule.nctId
"NCT07537517"
protocolSection.identificationModule.officialTitle
"Evaluation of the BMPR2-Activin Signaling Pathway as a Key Mediator in Group II Pulmonary Hypertension. BREATHE-PH Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pulmonary Hypertension Due to Left Heart Disease (protocolSection.conditionsModule.conditions)
  • Pulmonary Hypertension (PH) (protocolSection.conditionsModule.conditions)
  • Heart Failure (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.